These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16699258

  • 1. Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination.
    Song JY, Cheong HJ, Ha SH, Kee SY, Jeong HW, Kim WJ.
    Am J Nephrol; 2006; 26(2):206-11. PubMed ID: 16699258
    [Abstract] [Full Text] [Related]

  • 2. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T.
    Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
    [Abstract] [Full Text] [Related]

  • 3. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD.
    Vaccine; 2004 Jun 02; 22(17-18):2199-201. PubMed ID: 15149777
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P.
    Am J Kidney Dis; 2009 Jul 02; 54(1):77-85. PubMed ID: 19339089
    [Abstract] [Full Text] [Related]

  • 5. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC.
    J Med Virol; 2009 May 02; 81(5):908-14. PubMed ID: 19319953
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P, Changsirikulchai S, Limkunakul C, Prachukthum P, Punpiput P, Buppanharun R, Chotpitayasunondh C.
    Vaccine; 2012 Feb 01; 30(6):1108-14. PubMed ID: 22178515
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of the trivalent influenza vaccination in Thai patients with hemodialysis or kidney transplant compared with healthy volunteers.
    Krairittichai U, Chittaganpitch M.
    J Med Assoc Thai; 2013 Mar 01; 96 Suppl 3():S1-7. PubMed ID: 23682516
    [Abstract] [Full Text] [Related]

  • 8. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Dramé M, Gillard P, van der Most R, Van Mechelen M, Hanon E, Leroux-Roels G.
    Vaccine; 2010 Jan 08; 28(3):849-57. PubMed ID: 19835828
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect of a booster dose of influenza vaccine in hemodialysis patients.
    Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, Logias F, Perego A, Zanetti AR.
    J Med Virol; 2007 Aug 08; 79(8):1176-9. PubMed ID: 17596830
    [Abstract] [Full Text] [Related]

  • 10. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep 08; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 11. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
    Hatz C, von Sonnenburg F, Casula D, Lattanzi M, Leroux-Roels G.
    Vaccine; 2012 May 14; 30(23):3470-7. PubMed ID: 22446638
    [Abstract] [Full Text] [Related]

  • 12. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 14; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 13. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
    Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P.
    Vaccine; 2006 Nov 10; 24(44-46):6620-3. PubMed ID: 16870313
    [Abstract] [Full Text] [Related]

  • 14. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E, Boschini A, Amendola A, Poletti R, Anselmi G, Begnini M, Ranghiero A, Cecconi G, Zanetti AR.
    Vaccine; 2011 Nov 15; 29(49):9209-13. PubMed ID: 21974995
    [Abstract] [Full Text] [Related]

  • 15. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
    Kung HC, Huang KC, Kao TM, Lee YC, Chang FY, Wang NC, Liu YC, Lee WS, Liu HJ, Chen CI, Chen CH, Huang LM, Hsieh SM.
    Vaccine; 2010 Oct 21; 28(45):7337-43. PubMed ID: 20817013
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities.
    den Elzen WP, Vossen AC, Cools HJ, Westendorp RG, Kroes AC, Gussekloo J.
    Vaccine; 2011 Jun 24; 29(29-30):4869-74. PubMed ID: 21497631
    [Abstract] [Full Text] [Related]

  • 17. Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population.
    Matsushita M, Takeuchi S, Kumagai N, Uehara Y, Matsushita C, Arise K, Seo H, Awatani T.
    Vaccine; 2012 Feb 01; 30(6):1101-7. PubMed ID: 22178518
    [Abstract] [Full Text] [Related]

  • 18. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Rheumatology (Oxford); 2009 Oct 01; 48(10):1294-9. PubMed ID: 19692457
    [Abstract] [Full Text] [Related]

  • 19. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
    Gildea S, Arkins S, Walsh C, Cullinane A.
    Vaccine; 2011 May 17; 29(22):3917-22. PubMed ID: 21419776
    [Abstract] [Full Text] [Related]

  • 20. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
    Vesikari T, Groth N, Karvonen A, Borkowski A, Pellegrini M.
    Vaccine; 2009 Oct 23; 27(45):6291-5. PubMed ID: 19840662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.